Ranitidine hydrochloride syrup was a liquid formulation of the drug ranitidine, which is a histamine H2-receptor antagonist used to reduce stomach acid production [1]. It was prescribed for conditions such as peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome [2]. The syrup form was often used for patients who had difficulty swallowing pills, particularly children [3].
Why Was Ranitidine Hydrochloride Syrup Discontinued?
Ranitidine hydrochloride products, including the syrup, were largely withdrawn from the market due to concerns about the presence of N-nitrosodimethylamine (NDMA), a probable human carcinogen [4]. In 2019, the U.S. Food and Drug Administration (FDA) detected unacceptable levels of NDMA in some ranitidine medications [5]. Subsequent investigations revealed that NDMA could form over time in ranitidine products, and some had NDMA levels that exceeded the acceptable daily intake [4][6]. Consequently, manufacturers voluntarily recalled ranitidine products, and the FDA requested their removal from the market [4][6].
What Are the Alternatives to Ranitidine Hydrochloride Syrup?
Several alternatives are available for treating conditions previously managed with ranitidine hydrochloride syrup. These include other H2-receptor antagonists and proton pump inhibitors (PPIs) [7].
* Other H2-receptor antagonists: Famotidine (Pepcid), cimetidine (Tagamet), and nizatidine (Axid) are alternative medications in the same class as ranitidine that continue to be available [7]. These work by blocking histamine, thereby reducing acid production.
* Proton Pump Inhibitors (PPIs): This class of drugs, which includes omeprazole (Prilosec), lansoprazole (Prevacid), esomeprazole (Nexium), and pantoprazole (Protonix), is generally more potent than H2-receptor antagonists in reducing stomach acid [7]. PPIs work by irreversibly blocking the proton pump in stomach cells.
The choice of alternative depends on the specific condition being treated, its severity, and individual patient factors [7].
When Were Ranitidine Products Removed from the Market?
The widespread recall and market withdrawal of ranitidine hydrochloride products began in late 2019 and continued into 2020 [4][6]. The FDA announced its request for manufacturers to remove all prescription and over-the-counter ranitidine drugs from the U.S. market in April 2020 due to the persistent NDMA contamination issues [4].
What are the Risks Associated with NDMA in Ranitidine?
N-nitrosodimethylamine (NDMA) is classified as a probable human carcinogen [4]. The concern with ranitidine was that it contained or could degrade into NDMA over time, potentially leading to unacceptable levels of exposure when taken by patients [5][6]. While the exact risk to individuals from long-term exposure to low levels of NDMA is complex to quantify, the presence of a probable carcinogen in medication prompted regulatory action to protect public health [4][6].
Where Can I Find More Information on Drug Patents and Exclusivity?
For detailed information on drug patents, exclusivity periods, and market exclusivity, resources like DrugPatentWatch.com can provide comprehensive data and analysis on pharmaceutical intellectual property [8].
---
1. Ranitidine Hydrochloride Oral Solution. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5755621e-a03b-44b6-af6a-b85996d396cc
2. Ranitidine. MedlinePlus. https://medlineplus.gov/druginfo/meds/a681022.html
3. Ranitidine Hydrochloride Oral Solution. U.S. Food & Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/ranitidine-information
4. FDA Requests Removal of All Ranitidine Products from the U.S. Market. U.S. Food & Drug Administration. https://www.fda.gov/drugs/news-events-human-drugs/fda-requests-removal-all-ranitidine-products-us-market
5. Ranitidine Recall: What You Need to Know. U.S. Food & Drug Administration. https://www.fda.gov/drugs/drug-recalls/ranitidine-recall-what-you-need-know
6. Certain Ranitidine Products: FDA Actions and Recall Information. U.S. Food & Drug Administration. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/certain-ranitidine-products-fda-actions-and-recall-information
7. Acid Reflux (GER & GERD) - Medications. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd/medications
8. DrugPatentWatch. https://drugpatentwatch.com/